Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, today announced that its next generation disposable EEG cap, NeuroCap(TM), will now be available to the pediatric market across the United States. According to the update, the product launch allows Brain Scientific to bring faster, more efficient and sanitary testing procedures to U.S. pediatric professionals. “The NeuroCap headset is ready to be utilized in facilities across the country, and now with the pediatric size cap we can reach even more patients who need access to sanitary, convenient and prompt EEG testing,” said Irina Nazarova, marketing director of Brain Scientific. “We are thrilled to roll out a needed solution within pediatrics that is easily and affordably implemented in healthcare facilities for clinicians to use with precision and confidence.”
To view the full press release, visit https://ibn.fm/r2XzD
About Brain Scientific
Brain Scientific is a commercial-stage health care company with two FDA-cleared products, providing next-gen solutions to the neurology market. The company’s smart diagnostic devices and sensors simplify administration, shorten scan time and cut costs, allowing clinicians to make rapid decisions remotely and bridge the widening gap in access to neurological care. To learn more about the company’s corporate strategy, devices or for investor relations, visit www.BrainScientific.com.
NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork